دورية أكاديمية

Seroprevalence of SARS-CoV-2 among high-density communities and hyper-endemicity of COVID-19 in Vietnam.

التفاصيل البيبلوغرافية
العنوان: Seroprevalence of SARS-CoV-2 among high-density communities and hyper-endemicity of COVID-19 in Vietnam.
المؤلفون: Hoang VT; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Pham TD; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Nguyen QT; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Nguyen DC; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Nguyen DT; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Nguyen TB; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Tran TKT; Thai Binh Province General Hospital, Thai Binh, Vietnam., Phan TL; General Department of Preventive Medicine, Ministry of Health, Ha Noi, Vietnam., Vo PLN; People's Committee of Nha Be District, Ho Chi Minh City, Vietnam., Dao TL; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam., Fenollar F; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.; IHU-Méditerranée Infection, Marseille, France., Gautret P; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
المصدر: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2022 May; Vol. 27 (5), pp. 515-521. Date of Electronic Publication: 2022 Mar 25.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9610576 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-3156 (Electronic) Linking ISSN: 13602276 NLM ISO Abbreviation: Trop Med Int Health Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Blackwell Scientific Publications
Original Publication: Oxford, UK : Blackwell Science Ltd, c1996-
مواضيع طبية MeSH: COVID-19*/diagnosis , COVID-19*/epidemiology , SARS-CoV-2*, Adult ; Antibodies, Viral ; Humans ; Immunoglobulin M ; Seroepidemiologic Studies ; Vietnam/epidemiology
مستخلص: Objective: To assess the magnitude of active and recovering COVID-19 patients among at-risk communities and to identify the factors associated with positive serology.
Methods: Four hundred and eighty-three close contacts of COVID-19 patients residing in Ho Chi Minh City, Vietnam, during the fourth wave of the COVID-19 epidemic (September and October 2021) were included. Five weeks after exposure to a COVID-19 patient, they underwent a serology test using the BIOSYNEX COVID-19 BSS kit.
Results: The median age of participants was 37 years. A total of 34.6% individuals presented at least one clinical symptom between the time of contact with the COVID-19 patient and inclusion in study. A total of 1.7% unvaccinated individuals tested positive for SARS-CoV-2 using real-time PCR, and 9.5% had evidence of recent infection (positive PCR and/or IgM). A further 26.7% unvaccinated individuals presented evidence of a past infection (positive IgG only). Socio-demographic characteristics, vaccination status and clinical symptoms were not associated with a positive IgM test.
Conclusion: This is the first serosurvey conducted during the fourth wave of the epidemic in Vietnam. It revealed a seropositivity rate higher than in previous studies and confirmed the hyperendemicity of SARS-CoV-2. Testing using rapid serological tests proved to be a reliable, easy-to-use method and enabled a rapid estimation of the burden of COVID-19.
(© 2022 John Wiley & Sons Ltd.)
References: PLoS One. 2020 Oct 15;15(10):e0240779. (PMID: 33057446)
J Infect. 2021 Jan;82(1):e36-e37. (PMID: 33221367)
Euro Surveill. 2020 Jun;25(24):. (PMID: 32583766)
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234. (PMID: 36340059)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Trop Med Int Health. 2022 May;27(5):515-521. (PMID: 35303386)
Emerg Microbes Infect. 2021 Dec;10(1):2276-2278. (PMID: 34792434)
J Infect. 2020 Sep;81(3):420-426. (PMID: 32504745)
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076. (PMID: 32172228)
Travel Med Infect Dis. 2020 May - Jun;35:101711. (PMID: 32360326)
J Med Virol. 2020 Nov;92(11):2887-2890. (PMID: 32779765)
IJID Reg. 2022 Mar;2:137-140. (PMID: 35721423)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
J Clin Virol. 2020 Jun;127:104379. (PMID: 32361325)
Emerg Infect Dis. 2021 Feb;27(2):636-638. (PMID: 33349310)
N Engl J Med. 2020 Feb 27;382(9):872-874. (PMID: 31991079)
Lancet. 2020 Aug 1;396(10247):313-319. (PMID: 32534626)
Nat Med. 2020 Aug;26(8):1193-1195. (PMID: 32504052)
Clin Infect Dis. 2021 May 4;72(9):e412-e414. (PMID: 32687149)
JAMA Intern Med. 2020 Jul 21;:. (PMID: 32692365)
Travel Med Infect Dis. 2020 Sep - Oct;37:101822. (PMID: 32653477)
Science. 2021 Feb 26;371(6532):916-921. (PMID: 33479118)
N Engl J Med. 2020 Aug 6;383(6):e37. (PMID: 32501664)
Nat Commun. 2021 Feb 10;12(1):905. (PMID: 33568663)
Br Dent J. 2020 Oct;229(8):521-524. (PMID: 33097885)
Int J Infect Dis. 2021 Oct;111:127-129. (PMID: 34339862)
BMJ Glob Health. 2020 Aug;5(8):. (PMID: 32819917)
Global Health. 2020 Nov 19;16(1):112. (PMID: 33213482)
Am J Trop Med Hyg. 2022 Jan 26;106(3):891-895. (PMID: 35081510)
Antiviral Res. 2020 Sep;181:104880. (PMID: 32679056)
Int J Environ Res Public Health. 2021 Jun 11;18(12):. (PMID: 34208212)
Euro Surveill. 2020 Jul;25(28):. (PMID: 32700672)
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. (PMID: 32979314)
Clin Microbiol Infect. 2021 Mar;27(3):331-340. (PMID: 33228974)
J Med Virol. 2021 Apr;93(4):2196-2203. (PMID: 33107601)
J Prev Med Hyg. 2022 Apr 26;63(1):E166-E173. (PMID: 35647376)
Nat Med. 2020 Jun;26(6):849-854. (PMID: 32382154)
Pan Afr Med J. 2021 Aug 06;39:228. (PMID: 34630840)
Lancet. 2020 Aug 22;396(10250):535-544. (PMID: 32645347)
Lancet Reg Health West Pac. 2021 Mar;8:100113. (PMID: 33681829)
فهرسة مساهمة: Keywords: COVID-19; SARS-CoV-2; Vietnam; high-density communities; seroprevalence
المشرفين على المادة: 0 (Antibodies, Viral)
0 (Immunoglobulin M)
تواريخ الأحداث: Date Created: 20220318 Date Completed: 20220505 Latest Revision: 20230916
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9115418
DOI: 10.1111/tmi.13744
PMID: 35303386
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-3156
DOI:10.1111/tmi.13744